HCM
NVS icon

Hudson Capital Management’s Novartis NVS Stock Holding History

Hudson Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$320K Hold
2,040
– – 0.08% 62
2026
Q1 		$312K Hold
2,040
– – 0.08% 60
2025
Q4 		$281K Sell
2,040
-8
-0.4% -$1.05K 0.07% 58
2025
Q3 		$263K Hold
2,048
– – 0.07% 60
2025
Q2 		$248K Buy
+2,048
New +$231K 0.07% 65

Other funds holding NVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GGI
Godsey & Gibb Inc Richmond, Virginia $1.22B AUM 27.93% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
MIM
Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Hudson Capital Management's NVS Position: Q2 2026 in Review

Hudson Capital Management held its Novartis (NVS) position steady in Q2 2026 at 2,040 shares worth $320K. The position accounts for 0.08% of the portfolio, ranked #62.

Hudson Capital Management first reported a position in NVS in Q2 2025 and has held it in 5 quarters since. 509 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Hudson Capital Management held 2,040 shares of Novartis worth $320K as of Q2 2026.
  • Hudson Capital Management left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.08% of Hudson Capital Management's portfolio in Q2 2026, its #62 holding.
  • Hudson Capital Management first reported a position in Novartis in Q2 2025 and has held it in 5 quarters since.
  • 509 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Hudson Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.